⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 31, 2017Science Translational MedicineOpen Access

Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief

View Full Paper

Ask AI

Bookmark

Share

Abstract

R in the complex pathophysiology of pain and demonstrate the use of endosomally targeted GPCR antagonists.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jensen et al. (2017) studied this question.

synapsesocial.com/papers/6aaa1335bf5b892176fca020 https://doi.org/10.1126/scitranslmed.aal3447

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Protein kinase C-mediated desensitization of the neurokinin 1 receptorOriginal Research · 2001 · 46 citations
2Recycling and Resensitization of the Neurokinin 1 ReceptorOriginal Research · 2004 · 86 citations
3A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase COriginal Research · 2003 · 554 citations
4Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitorsOriginal Research · 2013 · 263 citations
5Distinct pools of cAMP centre on different isoforms of adenylyl cyclase in pituitary-derived GH3B6 cellsOriginal Research · 2009 · 77 citations